NCT02450864

The Biological Effect of ESWT and the Role of Proinflammatory Cytokines and Cannabinoid Receptor in Shoulder Stiffness

Status unknown NA Last updated 7 February 2017

What this trial tests

NA trial testing ESWT in Stiffness of Shoulder, Not Elsewhere Classified in 100 participants. Status unknown.

Timeline

1 January 2013

Primary endpoint
31 July 2019

31 July 2019

Quick facts

Lead sponsor	Chang Gung Memorial Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	diagnostic
Enrollment	100
Start date	1 January 2013
Primary completion	31 July 2019
Estimated completion	31 July 2019
Sites	1 location across Taiwan

Drugs / interventions tested

• ESWT

Conditions studied

• Stiffness of Shoulder, Not Elsewhere Classified — all drugs for Stiffness of Shoulder, Not Elsewhere Classified →

Sponsor

Chang Gung Memorial Hospital

Who can join

Adults 18 to 80, any sex, with Stiffness of Shoulder, Not Elsewhere Classified. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators recent data showed anti-inflammatory effect of Effect of Extracorporeal Shockwave Technology (ESWT). Little studies focused on the effect and pathomechanism of ESWT on shoulder stiffness.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. The Therapeutic Effects of Extracorporeal Shock Wave Therapy (ESWT) on the Rotator Cuff Lesions with Shoulder Stiffness: A Prospective Randomized Study.
   Ko JY, Siu KK, Wang FS, Wang CJ, et al · · 2020 · cited 7× · PMID 35912378 · DOI 10.1155/2020/6501714